| Brendan William Munzer, MD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Brendan William Munzer |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285072538 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301103088 (Michigan) | Primary |
| Entity Name | Chelsea Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912947409 PECOS PAC ID: 0648171074 Enrollment ID: O20040119000004 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
Now, in a study that appears in the May 10, 2012 issue of the journal Neuron, scientists from the Florida campus of The Scripps Research Institute have pinpointed a mechanism that is essential for forming memories in the first place and, as it turns out, is equally essential for eliminating them after memories have formed.
Scientists have created an app that uses Smartphone selfies to detect pancreatic cancer while it is in the early stages.
The Wall Street Journal examines GlaxoSmithKline's plan to share its database of compounds that could treat tropical diseases. The initiative will test how well "open-source principles work for developing new drugs," the newspaper reports.
› Verified 4 days ago
| Entity Name | Epmg Of Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386688992 PECOS PAC ID: 4789596339 Enrollment ID: O20040211000686 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
Now, in a study that appears in the May 10, 2012 issue of the journal Neuron, scientists from the Florida campus of The Scripps Research Institute have pinpointed a mechanism that is essential for forming memories in the first place and, as it turns out, is equally essential for eliminating them after memories have formed.
Scientists have created an app that uses Smartphone selfies to detect pancreatic cancer while it is in the early stages.
The Wall Street Journal examines GlaxoSmithKline's plan to share its database of compounds that could treat tropical diseases. The initiative will test how well "open-source principles work for developing new drugs," the newspaper reports.
› Verified 4 days ago
| Entity Name | Hospitalist Physicians Medical Group Of Michigan, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003978867 PECOS PAC ID: 4688778228 Enrollment ID: O20070409000434 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
Now, in a study that appears in the May 10, 2012 issue of the journal Neuron, scientists from the Florida campus of The Scripps Research Institute have pinpointed a mechanism that is essential for forming memories in the first place and, as it turns out, is equally essential for eliminating them after memories have formed.
Scientists have created an app that uses Smartphone selfies to detect pancreatic cancer while it is in the early stages.
The Wall Street Journal examines GlaxoSmithKline's plan to share its database of compounds that could treat tropical diseases. The initiative will test how well "open-source principles work for developing new drugs," the newspaper reports.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brendan William Munzer, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Brendan William Munzer, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).
A UBC medical student has determined that a new surgical guideline is making a difference for breast cancer patients.
Now, in a study that appears in the May 10, 2012 issue of the journal Neuron, scientists from the Florida campus of The Scripps Research Institute have pinpointed a mechanism that is essential for forming memories in the first place and, as it turns out, is equally essential for eliminating them after memories have formed.
Scientists have created an app that uses Smartphone selfies to detect pancreatic cancer while it is in the early stages.
The Wall Street Journal examines GlaxoSmithKline's plan to share its database of compounds that could treat tropical diseases. The initiative will test how well "open-source principles work for developing new drugs," the newspaper reports.
› Verified 4 days ago
Timothy Patrick Visclosky, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Phillip Alton Scott, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Kylee E Phillips, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Drive, B1 Floor University Hospital Recp Emergency, Ann Arbor, MI 48109 Phone: 734-936-6666 | |
Abhinav Nafday, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Drive, Ann Arbor, MI 48109 Phone: 734-763-7919 Fax: 734-763-9298 | |
John C Baselle, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2000 Green Rd, Suite 100, Ann Arbor, MI 48105 Phone: 734-995-3764 Fax: 208-475-9028 | |
Robert W Neumar, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Scott Richard Ferguson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, B1-380 Tc, Ann Arbor, MI 48109 Phone: 734-763-7919 Fax: 734-763-9298 |